ARQT
#1727
Arcutis Biotherapeutics, Inc. - Common stock
23.7 8 USD
-0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.38%
Monthly Change
-14.37%
6 month change
-7.47%
Year Change
+53.82%
Previous Close
24.8 7
Open
23.7 8
Low
23.7 8
High
23.7 8
Volume
99
Financials
- Market Capitalization 2.99 B
- Employee 354
- Founded 2016
- CEO Frank Watanabe
- Website www.arcutis.com
- Headquarter Delaware, United States
- FIGI BBG00QN8K4M4
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-223.38
Price to sales ratio
9.82
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1704 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 39.12 USD | -3.31% | -2.59% | +1.61% | +43.61% | 3.07 B USD | ||
| 1719 |  BEAM Beam Therapeutics Inc. - Common Stock | 29.32 USD | -3.81% | +0.34% | +8.87% | +81.10% | 3.03 B USD | ||
| 1741 |  ZLAB Zai Lab Limited - American Depositary Shares | 26.08 USD | -2.76% | +2.35% | +43.06% | -2.29% | 2.93 B USD | ||
| 1748 |  ALMS Alumis Inc. - Common Stock | 22.38 USD | -3.58% | -5.53% | -22.69% | +396.23% | 2.90 B USD |
Frequently asked questions about Arcutis Biotherapeutics, Inc. Common Stock
What is the Arcutis Biotherapeutics, Inc. Common Stock stock price today?
The current price of Arcutis Biotherapeutics, Inc. Common Stock (ARQT) is 23.78. Over the past 24 hours, the stock has changed by -4.38%. Follow the ARQT chart for real-time price dynamics.
What is the stock ticker of Arcutis Biotherapeutics, Inc. Common Stock?
Arcutis Biotherapeutics, Inc. Common Stock trades under the ticker ARQT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Arcutis Biotherapeutics, Inc. Common Stock stock going up?
ARQT has changed by -4.11% over the last week, -14.37% over the last month, and +53.82% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Arcutis Biotherapeutics, Inc. Common Stock?
Arcutis Biotherapeutics, Inc. Common Stock currently has a market capitalization of 2.99 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Arcutis Biotherapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Arcutis Biotherapeutics, Inc. Common Stock reported earnings of 0.11 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Arcutis Biotherapeutics, Inc. Common Stock revenue for the last quarter?
Arcutis Biotherapeutics, Inc. Common Stock reported quarterly revenue of 129.86 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Arcutis Biotherapeutics, Inc. Common Stock net income for the last quarter?
Arcutis Biotherapeutics, Inc. Common Stock reported net income of 15.01 M for the last quarter. The previous quarter showed -11.29 M, which means net income changed by +232.88%.
How many employees does Arcutis Biotherapeutics, Inc. Common Stock have?
As of the latest available data, Arcutis Biotherapeutics, Inc. Common Stock has 354 employees. Workforce size can provide additional context about the company's scale and operations.
What is Arcutis Biotherapeutics, Inc. Common Stock EBITDA?
Arcutis Biotherapeutics, Inc. Common Stock EBITDA is 17.33 M, and its EBITDA margin is 13.35%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Arcutis Biotherapeutics, Inc. Common Stock stock?
You can buy Arcutis Biotherapeutics, Inc. Common Stock (ARQT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Arcutis Biotherapeutics, Inc. Common Stock stock?
Investing in Arcutis Biotherapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ARQT chart and related analysis on metatrader.com as part of your research.